Experimental trials of predicted CD4+ and CD8+ T-cell epitopes of respiratory syncytial virus

Experimental trials of predicted CD4+ and CD8+ T-cell epitopes of respiratory syncytial virus

BackgroundRespiratory syncytial virus (RSV) is the most common cause of viral lower respiratory tract infections (LRTIs) in young children around the world and an important cause of LRTI in the elderly. The available treatments and FDA-approved vaccines for RSV only lessen the severity of the infect...

Full description

Bibliographic Details
Main Authors: Syeda Tahira Qousain Naqvi, Syed Aun Muhammad, Jinlei Guo, Sidra Zafar, Amjad Ali, Larry J. Anderson, Christina A. Rostad, Baogang Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
RSV
prophylactic vaccine
healthy and diseased animal models
hematological and cellular assays
virus neutralization assay
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1349749/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1349749/full

Similar Items